Scientists demonstrated that upregulation of the splicing factor, RBM17 preferentially marked and sustained leukemic stem cells and directly correlated with shorten patient survival.
[Nature Communications]
Home Newsletters Hematopoiesis News The Splicing Factor RBM17 Drives Leukemic Stem Cell Maintenance by Evading Nonsense-Mediated...
